{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:39Z","timestamp":1787003619660,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The in-depth understanding of the dynamics of COVID-19 transmission among different age groups is of great interest for governments and health authorities so that strategies can be devised to reduce the pandemic\u2019s detrimental effects. We developed the SIRDV-Virulence (Susceptible-Infected-Recovered-Dead-Vaccinated-Virulence) epidemiological model based on a population balance equation to study the effects virus mutants, vaccination strategies, \u2018Anti\/Non Vaxxer\u2019 proportions, and reinfection rates to provide methods to mitigate COVID-19 transmission among the United States population. Based on publicly available data, we obtain the key parameters governing the spread of the pandemic. The results show that a large fraction of infected cases comes from the adult and children populations in the presence of a highly infectious COVID-19 mutant. Given the situation at the end of July 2021, the results show that prioritizing children and adult vaccinations over that of seniors can contain the spread of the active cases, thereby preventing the healthcare system from being overwhelmed and minimizing subsequent deaths. The model suggests that the only option to curb the effects of this pandemic is to reduce the population of unvaccinated individuals. A higher fraction of \u2018Anti\/Non-vaxxers\u2019 and a higher reinfection rate can both independently lead to the resurgence of the pandemic.<\/jats:p>","DOI":"10.1038\/s41598-022-21559-9","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T03:04:11Z","timestamp":1669172651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modeling COVID-19 transmission between age groups in the United States considering virus mutations, vaccinations, and reinfection"],"prefix":"10.1038","volume":"12","author":[{"given":"Jyotirmoy","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doraiswami","family":"Ramkrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"21559_CR1","first-page":"5","volume":"2020","author":"P Mo","year":"2020","unstructured":"Mo, P. et al. Clinical characteristics of refractory Covid-19 pneumonia in Wuhan, China. Clin. Infect. Dis. 2020, 5 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"21559_CR2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.cell.2020.06.040","volume":"182","author":"ND Grubaugh","year":"2020","unstructured":"Grubaugh, N. D., Hanage, W. P. & Rasmussen, A. L. Making sense of mutation: What d614g means for the Covid-19 pandemic remains unclear. Cell 182, 794\u2013795 (2020).","journal-title":"Cell"},{"key":"21559_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber, B. et al. Tracking changes in sars-cov-2 spike: Evidence that d614g increases infectivity of the Covid-19 virus. Cell 182, 812\u2013827 (2020).","journal-title":"Cell"},{"key":"21559_CR4","first-page":"2020040281","volume":"2020","author":"AK Banerjee","year":"2020","unstructured":"Banerjee, A. K., Begum, F. & Ray, U. Mutation hot spots in spike protein of Covid-19. Preprints 2020, 2020040281 (2020).","journal-title":"Preprints"},{"key":"21559_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-00265-5","volume":"6","author":"J Zou","year":"2021","unstructured":"Zou, J. et al. The effect of sars-cov-2 d614g mutation on bnt162b2 vaccine-elicited neutralization. NPJ Vacc. 6, 1\u20134 (2021).","journal-title":"NPJ Vacc."},{"key":"21559_CR6","first-page":"5","volume":"2021","author":"S Truelove","year":"2021","unstructured":"Truelove, S. et al. Projected resurgence of Covid-19 in the United States in July-December 2021 resulting from the increased transmissibility of the delta variant and faltering vaccination. medRxiv 2021, 5 (2021).","journal-title":"medRxiv"},{"key":"21559_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.15585\/mmwr.mm7023e2","volume":"70","author":"A Christie","year":"2021","unstructured":"Christie, A. et al. Decreases in Covid-19 cases, emergency department visits, hospital admissions, and deaths among older adults following the introduction of Covid-19 vaccine-United States, September 6, 2020-May 1, 2021. Morb. Mortal. Wkly. Rep. 70, 858 (2021).","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"21559_CR8","first-page":"6","volume":"2021","author":"SA Shah","year":"2021","unstructured":"Shah, S. A. et al. Predicted Covid-19 positive cases, hospitalisations, and deaths associated with the delta variant of concern, June-July, 2021. Lancet Dig. Health 2021, 6 (2021).","journal-title":"Lancet Dig. Health"},{"key":"21559_CR9","doi-asserted-by":"publisher","first-page":"e2034266","DOI":"10.1001\/jamanetworkopen.2020.34266","volume":"4","author":"DM Bravata","year":"2021","unstructured":"Bravata, D. M. et al. Association of intensive care unit patient load and demand with mortality rates in us department of veterans affairs hospitals during the Covid-19 pandemic. JAMA Netw. Open 4, e2034266\u2013e2034266 (2021).","journal-title":"JAMA Netw. Open"},{"key":"21559_CR10","first-page":"1","volume":"2020","author":"P Karaca-Mandic","year":"2020","unstructured":"Karaca-Mandic, P., Sen, S., Georgiou, A., Zhu, Y. & Basu, A. Association of Covid-19-related hospital use and overall Covid-19 mortality in the USA. J. Gen. Internal Med. 2020, 1\u20133 (2020).","journal-title":"J. Gen. Internal Med."},{"key":"21559_CR11","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","volume":"69","author":"M\u00c9 Czeisler","year":"2020","unstructured":"Czeisler, M. \u00c9. et al. Delay or avoidance of medical care because of Covid-19-related concerns-United States, June 2020. Morb. Mortal. Wkly. Rep. 69, 1250 (2020).","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"21559_CR12","doi-asserted-by":"publisher","first-page":"e2024984","DOI":"10.1001\/jamanetworkopen.2020.24984","volume":"3","author":"CM Whaley","year":"2020","unstructured":"Whaley, C. M. et al. Changes in health services use among commercially insured us populations during the Covid-19 pandemic. JAMA Netw. Open 3, e2024984\u2013e2024984 (2020).","journal-title":"JAMA Netw. Open"},{"key":"21559_CR13","first-page":"68","volume":"2021","author":"SM Moghadas","year":"2021","unstructured":"Moghadas, S. M. et al. The impact of vaccination on Covid-19 outbreaks in the United States. medRxiv 2021, 68 (2021).","journal-title":"medRxiv"},{"key":"21559_CR14","unstructured":"Centers for Disease Control and Prevention. Covid-19 vaccinations in the United States. https:\/\/covid.cdc.gov\/covid-data-tracker\/vaccinations (2021)."},{"key":"21559_CR15","unstructured":"Centers for Disease Control and Prevention. Clinical information about Covid-19 vaccinations in the United States. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/index.html (2021)."},{"key":"21559_CR16","doi-asserted-by":"publisher","first-page":"eaab5589","DOI":"10.1126\/scirobotics.abb5589","volume":"5","author":"G-Z Yang","year":"2020","unstructured":"Yang, G.-Z. et al. Combating Covid-19-the role of robotics in managing public health and infectious diseases. Sci. Robot. 5, eaab5589 (2020).","journal-title":"Sci. Robot."},{"key":"21559_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100495","volume":"26","author":"AA Malik","year":"2020","unstructured":"Malik, A. A., McFadden, S. M., Elharake, J. & Omer, S. B. Determinants of Covid-19 vaccine acceptance in the us. EClinicalMedicine 26, 100495 (2020).","journal-title":"EClinicalMedicine"},{"key":"21559_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.worlddev.2020.105177","volume":"136","author":"R Boodoosingh","year":"2020","unstructured":"Boodoosingh, R., Olayemi, L. O. & Sam, F.A.-L. Covid-19 vaccines: Getting anti-vaxxers involved in the discussion. World Dev. 136, 105177 (2020).","journal-title":"World Dev."},{"key":"21559_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(21)02046-8","volume":"398","author":"PR Krause","year":"2021","unstructured":"Krause, P. R. et al. Considerations in boosting Covid-19 vaccine immune responses. The Lancet 398, 1377\u20131380 (2021).","journal-title":"The Lancet"},{"key":"21559_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.3001211","volume":"19","author":"SM Moghadas","year":"2021","unstructured":"Moghadas, S. M. et al. Evaluation of Covid-19 vaccination strategies with a delayed second dose. PLoS Biol. 19, 1\u201313 (2021).","journal-title":"PLoS Biol."},{"key":"21559_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21385-z","volume":"12","author":"L Tian","year":"2021","unstructured":"Tian, L. et al. Harnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the covid-19 pandemic. Nat. Commun. 12, 1\u201312 (2021).","journal-title":"Nat. Commun."},{"key":"21559_CR22","unstructured":"The Guardian. South korea took rapid, intrusive measures against Covid-19-and they worked. https:\/\/www.theguardian.com\/commentisfree\/2020\/mar\/20\/south-korea-rapid-intrusive-measures-covid-19. (2022)."},{"key":"21559_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1057\/s41599-021-01017-z","volume":"9","author":"L Zhong","year":"2022","unstructured":"Zhong, L., Diagne, M., Wang, Q. & Gao, J. Vaccination and three non-pharmaceutical interventions determine the dynamics of Covid-19 in the us. Hum. Soc. Sci. Commun. 9, 1\u201312 (2022).","journal-title":"Hum. Soc. Sci. Commun."},{"key":"21559_CR24","first-page":"10","volume":"2021","author":"O Yagan","year":"2021","unstructured":"Yagan, O. et al. Modeling and analysis of the spread of Covid-19 under a multiple-strain model with mutations. Harvard Data Sci. Rev. 2021, 10 (2021).","journal-title":"Harvard Data Sci. Rev."},{"key":"21559_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.15585\/mmwr.mm7021e3","volume":"70","author":"C Covid","year":"2021","unstructured":"Covid, C. et al. Covid-19 vaccine breakthrough infections reported to cdc-United States, January 1-April 30, 2021. Morb. Mort. Wkly. Rep. 70, 792 (2021).","journal-title":"Morb. Mort. Wkly. Rep."},{"key":"21559_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25915-7","volume":"12","author":"L Dyson","year":"2021","unstructured":"Dyson, L. et al. Possible future waves of sars-cov-2 infection generated by variants of concern with a range of characteristics. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"21559_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.593417","volume":"9","author":"DM Rubin","year":"2021","unstructured":"Rubin, D. M. et al. Facilitating understanding, modeling and simulation of infectious disease epidemics in the age of Covid-19. Front. Public Health 9, 593417 (2021).","journal-title":"Front. Public Health"},{"key":"21559_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocs.2019.101027","volume":"37","author":"M Ehrhardt","year":"2019","unstructured":"Ehrhardt, M., Ga\u0161per, J. & Kilianov\u00e1, S. Sir-based mathematical modeling of infectious diseases with vaccination and waning immunity. J. Comput. Sci. 37, 101027 (2019).","journal-title":"J. Comput. Sci."},{"key":"21559_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1183\/13993003.01112-2020","volume":"55","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Association between age and clinical characteristics and outcomes of Covid-19. Eur. Respir. J. 55, 5 (2020).","journal-title":"Eur. Respir. J."},{"key":"21559_CR30","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/ijms18061294","volume":"18","author":"EJ Miller","year":"2017","unstructured":"Miller, E. J. & Linge, H. M. Age-related changes in immunological and physiological responses following pulmonary challenge. Int. J. Mol. Sci. 18, 1294 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"21559_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Clinical course and outcomes of critically ill patients with sars-cov-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 8, 475\u2013481 (2020).","journal-title":"Lancet Respir. Med."},{"key":"21559_CR32","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China: A retrospective cohort study. The lancet 395, 1054\u20131062 (2020).","journal-title":"The lancet"},{"key":"21559_CR33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, china. JAMA Intern. Med. 180, 934\u2013943 (2020).","journal-title":"JAMA Intern. Med."},{"key":"21559_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1183\/13993003.00524-2020","volume":"55","author":"R-H Du","year":"2020","unstructured":"Du, R.-H. et al. Predictors of mortality for patients with Covid-19 pneumonia caused by sars-cov-2: A prospective cohort study. Eur. Respir. J. 55, 6 (2020).","journal-title":"Eur. Respir. J."},{"key":"21559_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236237","volume":"15","author":"M Chikina","year":"2020","unstructured":"Chikina, M. & Pegden, W. Modeling strict age-targeted mitigation strategies for Covid-19. PLoS ONE 15, e0236237 (2020).","journal-title":"PLoS ONE"},{"key":"21559_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijid.2020.06.101","volume":"98","author":"X Yu","year":"2020","unstructured":"Yu, X., Duan, J., Jiang, Y. & Zhang, H. Distinctive trajectories of the Covid-19 epidemic by age and gender: A retrospective modeling of the epidemic in south korea. Int. J. Infect. Dis. 98, 200\u2013205 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"21559_CR37","doi-asserted-by":"publisher","first-page":"24180","DOI":"10.1073\/pnas.2011656117","volume":"117","author":"LJ Thomas","year":"2020","unstructured":"Thomas, L. J. et al. Spatial heterogeneity can lead to substantial local variations in Covid-19 timing and severity. Proc. Natl. Acad. Sci. 117, 24180\u201324187 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"21559_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79817-7","volume":"10","author":"S Wang","year":"2020","unstructured":"Wang, S. & Ramkrishna, D. A model to rate strategies for managing disease due to Covid-19 infection. Sci. Rep. 10, 1\u201310 (2020).","journal-title":"Sci. Rep."},{"key":"21559_CR39","volume-title":"Population Balances: Theory and Applications to Particulate Systems in Engineering","author":"D Ramkrishna","year":"2000","unstructured":"Ramkrishna, D. Population Balances: Theory and Applications to Particulate Systems in Engineering (Elsevier, Hoboken, 2000)."},{"key":"21559_CR40","doi-asserted-by":"publisher","DOI":"10.1017\/9780511731969","volume-title":"Cybernetic Modeling for Bioreaction Engineering","author":"D Ramkrishna","year":"2018","unstructured":"Ramkrishna, D. & Song, H.-S. Cybernetic Modeling for Bioreaction Engineering (Cambridge University Press, Cambridge, 2018)."},{"key":"21559_CR41","unstructured":"Centers for Disease Control and Prevention. Sars-cov-2 variant classifications and definitions. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant.html (2021)."},{"key":"21559_CR42","unstructured":"Centers for Disease Control and Prevention. Variants of the virus that causes Covid-19. www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant.html (2022)."},{"key":"21559_CR43","unstructured":"Centers for Disease Control and Prevention. Monitoring variant proportions. https:\/\/covid.cdc.gov\/covid-data-tracker\/variant-proportions (2022)."},{"key":"21559_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"2021","author":"J Lopez-Bernal","year":"2021","unstructured":"Lopez-Bernal, J. et al. Effectiveness of covid-19 vaccines against the b. 1.617. 2 (delta) variant. N. Engl. J. Med. 2021, 585\u2013594 (2021).","journal-title":"N. Engl. J. Med."},{"key":"21559_CR45","first-page":"5","volume":"2021","author":"C Del Rio","year":"2021","unstructured":"Del Rio, C., Malani, P. N. & Omer, S. B. Confronting the delta variant of sars-cov-2, summer 2021. JAMA 2021, 5 (2021).","journal-title":"JAMA"},{"key":"21559_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78447-3","volume":"10","author":"J Grauer","year":"2020","unstructured":"Grauer, J., L\u00f6wen, H. & Liebchen, B. Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like covid-19. Sci. Rep. 10, 1\u201310 (2020).","journal-title":"Sci. Rep."},{"key":"21559_CR47","unstructured":"Centers for Disease Control and Prevention. Vaccination and case trends of covid-19 in the United States. https:\/\/covid.cdc.gov\/covid-data-tracker\/vaccinations-cases-trends (2021)."},{"key":"21559_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/JAC.0000000000000360","volume":"44","author":"A Coustasse","year":"2021","unstructured":"Coustasse, A., Kimble, C. & Maxik, K. Covid-19 and vaccine hesitancy: A challenge the United States must overcome. J. Ambul. Care Manag. 44, 71\u201375 (2021).","journal-title":"J. Ambul. Care Manag."},{"key":"21559_CR49","doi-asserted-by":"crossref","unstructured":"Dyer, O. In Covid-19: Omicron is Causing More Infections But Fewer Hospital Admissions than Delta, South African Data Show (2021).","DOI":"10.1136\/bmj.n3104"},{"key":"21559_CR50","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mco2.110","volume":"2","author":"X He","year":"2021","unstructured":"He, X., Hong, W., Pan, X., Lu, G. & Wei, X. Sars-cov-2 omicron variant: Characteristics and prevention. MedComm 2, 838\u2013845 (2021).","journal-title":"MedComm"},{"key":"21559_CR51","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the omicron (b. 1.1. 529) variant. N. Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"key":"21559_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.hrtlng.2020.03.017","volume":"49","author":"MA Marinella","year":"2020","unstructured":"Marinella, M. A. Covid-19 pandemic and the stethoscope: Do not forget to sanitize. Heart Lung 49, 350 (2020).","journal-title":"Heart Lung"},{"key":"21559_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/vaccines9050467","volume":"9","author":"A Pormohammad","year":"2021","unstructured":"Pormohammad, A. et al. Efficacy and safety of Covid-19 vaccines: A systematic review and meta-analysis of randomized clinical trials. Vaccines 9, 467 (2021).","journal-title":"Vaccines"},{"key":"21559_CR54","unstructured":"Centers for Disease Control and Prevention. Covid-19 vaccinations in the United States, jurisdiction. https:\/\/data.cdc.gov\/Vaccinations\/COVID-19-Vaccinations-in-the-United-States-Jurisdi\/unsk-b7fc (2021)."},{"key":"21559_CR55","unstructured":"United States Census Bureau. US and world population clock. https:\/\/www.census.gov\/popclock\/ (2022)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21559-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21559-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21559-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:01:58Z","timestamp":1669212118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21559-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21559"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21559-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20098"}}